Acrolein activates matrix metalloproteinases by increasing reactive oxygen species in macrophages.

Toxicology and Applied Pharmacology
Timothy E O'TooleA Bhatnagar


Acrolein is a ubiquitous component of environmental pollutants such as automobile exhaust, cigarette, wood, and coal smoke. It is also a natural constituent of several foods and is generated endogenously during inflammation or oxidation of unsaturated lipids. Because increased inflammation and episodic exposure to acrolein-rich pollutants such as traffic emissions or cigarette smoke have been linked to acute myocardial infarction, we examined the effects of acrolein on matrix metalloproteinases (MMPs), which destabilize atherosclerotic plaques. Our studies show that exposure to acrolein resulted in the secretion of MMP-9 from differentiated THP-1 macrophages. Acrolein-treatment of macrophages also led to an increase in reactive oxygen species (ROS), free intracellular calcium ([Ca2+](i)), and xanthine oxidase (XO) activity. ROS production was prevented by allopurinol, but not by rotenone or apocynin and by buffering changes in [Ca2+](I) with BAPTA-AM. The increase in MMP production was abolished by pre-treatment with the antioxidants Tiron and N-acetyl cysteine (NAC) or with the xanthine oxidase inhibitors allopurinol or oxypurinol. Finally, MMP activity was significantly stimulated in aortic sections from apoE-null mice contai...Continue Reading


Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K NakazonoM Inoue
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S D CushingA M Fogelman
Jan 1, 1991·Free Radical Biology & Medicine·H EsterbauerH Zollner
Jan 1, 1990·Free Radical Biology & Medicine·U P SteinbrecherM Lougheed
Feb 1, 1985·Journal of Molecular and Cellular Cardiology·D E ChambersJ M Downey
Nov 1, 1982·Canadian Journal of Physiology and Pharmacology·J M McCord, R S Roy
Mar 21, 1983·Life Sciences·G L Tritsch, P W Niswander
Oct 1, 1984·Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association·R J LevineL K Shaw
Aug 1, 1995·Free Radical Biology & Medicine·J A GimpelJ F Hitchcock
Jan 17, 1995·Proceedings of the National Academy of Sciences of the United States of America·Z S GalisP Libby
Feb 1, 1993·International Journal of Epidemiology·L AlfredssonC Hogstedt
Jan 26, 1996·Biochemical and Biophysical Research Communications·R CariniE Albano
Aug 22, 1997·The Journal of Biological Chemistry·D Steinberg
Aug 26, 1998·Journal of the American College of Cardiology·H KaiT Imaizumi
Mar 30, 1999·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·P FerdinandyM T Droy-lefaix
Sep 29, 1999·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·A SweiG W Schmid-Schönbein
Apr 15, 2000·Toxicology and Applied Pharmacology·J M HyvelinR Marthan
Mar 10, 2001·Cell·C K Glass, J L Witztum
Jan 5, 2002·Physiological Reviews·Wulf Dröge
May 7, 2002·Nature Reviews. Cancer·Mikala Egeblad, Zena Werb
May 16, 2002·Chest·Teresa D Tetley
Jul 10, 2002·Circulation·Colin A J FarquharsonAllan D Struthers
Jan 29, 2003·Circulation·Sashi GuthikondaWilliam G Haynes
Mar 21, 2003·The American Journal of Cardiology·David HarrisonHelmut Drexler
Jan 13, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Aruni Bhatnagar
Aug 12, 2004·Free Radical Biology & Medicine·Kristin K Nelson, J Andres Melendez

❮ Previous
Next ❯


Oct 2, 2013·North American Journal of Medical Sciences·Jacinta C UzoigweMahdi Garelnabi
Jul 3, 2013·Oxidative Medicine and Cellular Longevity·Seung Eun Lee, Yong Seek Park
May 9, 2014·Toxicological Sciences : an Official Journal of the Society of Toxicology·Timothy E O'TooleAruni Bhatnagar
Jan 5, 2016·Journal of the Air & Waste Management Association·Xi ChenShengji Luan
Apr 24, 2012·The Laryngoscope·Nathan S AlexanderBradford A Woodworth
Jul 5, 2012·Annals of the New York Academy of Sciences·Nadia MorettoFabrizio Facchinetti
Jun 30, 2011·Molecular Nutrition & Food Research·Qin ZhuMingfu Wang
Sep 13, 2013·Mediators of Inflammation·Daniela VecchioConcetta Gardi
Jun 19, 2013·Free Radical Biology & Medicine·Umesh C S YadavSatish K Srivastava
Nov 1, 2011·Free Radical Biology & Medicine·Gabriella LeonarduzziGiuseppe Poli
Sep 7, 2012·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Ian M FearonBrian K Nordskog
Mar 5, 2011·Atherosclerosis·Sanjay SrivastavaAruni Bhatnagar
Aug 16, 2014·Cardiovascular Toxicology·Christina M PerezAimen K Farraj
Jan 30, 2015·Toxicological Sciences : an Official Journal of the Society of Toxicology·Akshata MogheSwati Joshi-Barve
Apr 5, 2017·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Zivar YousefipourMohammad A Newaz
Dec 15, 2017·Antioxidants & Redox Signaling·Aladdin RiadSampath Parthasarathy
Feb 20, 2018·Oxidative Medicine and Cellular Longevity·Jung Hyun ParkJeen-Woo Park
Aug 8, 2014·Journal of the American Heart Association·Natasha DeJarnettAruni Bhatnagar
Jul 8, 2017·Circulation Research·Aruni Bhatnagar
Oct 19, 2016·Circulation·Geetha RaghuveerUNKNOWN American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in the Young of the Council on Cardiovasc
Sep 12, 2018·Toxicological Sciences : an Official Journal of the Society of Toxicology·Rui XiongXuefei Cao
Feb 18, 2010·Toxicology Mechanisms and Methods·Xing-yu LiuJian-ping Xie
Feb 16, 2010·American Journal of Physiology. Lung Cellular and Molecular Physiology·Daniela VecchioConcetta Gardi
Jan 18, 2015·The Journal of Biological Chemistry·Subhash HaldarNeil A Bhowmick
Feb 6, 2013·Nature Reviews. Cardiology·Adam Csordas, David Bernhard
Jan 14, 2017·Cardiovascular Toxicology·Robert J HenningRaymond D Harbison
May 10, 2017·Toxicological Sciences : an Official Journal of the Society of Toxicology·Daniel J ConklinSanjay Srivastava
Oct 11, 2017·Alternatives to Laboratory Animals : ATLA·Om MakwanaBetsy Bombick
Jul 10, 2020·Antioxidants & Redox Signaling·Erica GianazzaCristina Banfi
Jul 26, 2015·Inflammation·Brett D NoeragerPatricia L Jackson
Apr 11, 2017·ACS Omega·Mumiye A OgunwaleXiao-An Fu
Mar 6, 2019·Redox Biology·Erica GianazzaCristina Banfi

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.